Phase I and Pharmacokinetic Study of FB-642 [carbendazim] Administered Orally on a Weekly Schedule to Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 08 Aug 2012
At a glance
- Drugs Carbendazim (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 04 Oct 2005 New trial record.